Management of Abdominal Aortic Aneurysm
Patients with infrarenal or juxtarenal abdominal aortic aneurysms (AAAs) measuring 5.5 cm or larger should undergo repair to eliminate the risk of rupture. 1
Diagnosis and Screening
- One-time screening with ultrasonography is recommended for men 65-75 years of age who have ever smoked 1, 2
- Men 60 years of age or older who are siblings or offspring of patients with AAAs should undergo physical examination and ultrasound screening 1
- AAA is defined as a maximal diameter of the abdominal aorta exceeding 3.0 cm or a focal dilation ≥1.5 times the diameter of the normal adjacent arterial segment 3
- Major risk factors include age >60 years, smoking history, male gender, Caucasian race, and family history of AAA 3, 4
Surveillance for Asymptomatic AAAs
Surveillance Intervals Based on AAA Size:
- AAA <4.0 cm: Ultrasound examination every 2-3 years is reasonable 1
- AAA 4.0-5.4 cm: Monitor by ultrasound or CT scans every 6-12 months to detect expansion 1
- AAA ≥5.5 cm (men) or ≥5.0 cm (women): Repair is indicated 1
Imaging Modalities for Surveillance:
- Duplex ultrasound (DUS) is recommended as the primary surveillance method 1
- CT or MRI is recommended if DUS does not allow adequate measurement of AAA diameter 1
Indications for Intervention
Absolute Indications:
- Symptomatic AAAs regardless of diameter 1
- Infrarenal or juxtarenal AAAs ≥5.5 cm in men or ≥5.0 cm in women 1
- Rapid aneurysm growth (≥10 mm per year or ≥5 mm per 6 months) 1, 3
- Presence of the clinical triad of abdominal/back pain, pulsatile abdominal mass, and hypotension (indicating rupture) requires immediate surgical evaluation 1
Relative Indications:
- Repair can be beneficial in patients with infrarenal or juxtarenal AAAs 5.0-5.4 cm in diameter 1
- Repair is probably indicated in patients with suprarenal or type IV thoracoabdominal aortic aneurysms larger than 5.5-6.0 cm 1
Treatment Options
Surgical Approaches:
Open Repair:
Endovascular Aortic Repair (EVAR):
- Equally indicated in patients who are good surgical candidates 1
- Requires periodic long-term surveillance imaging to monitor for endoleak, graft position, and aneurysm sac stability 1
- Of uncertain effectiveness in patients at high surgical or anesthetic risk due to severe cardiac, pulmonary, and/or renal disease 1
Medical Management:
Blood Pressure Control:
Smoking Cessation:
Lipid Management:
- Statins have been shown to reduce cardiovascular mortality and slow the rate of AAA growth 5
Follow-up After Intervention
- After EVAR, periodic long-term surveillance imaging is required to monitor for 1:
- Endoleaks (particularly types I and III which most commonly lead to rupture)
- Graft position
- Aneurysm sac stability or shrinkage
- Need for further intervention
Common Pitfalls and Caveats
- Intervention is not recommended for asymptomatic infrarenal or juxtarenal AAAs if they measure less than 5.0 cm in diameter in men or less than 4.5 cm in women 1
- Surgical revascularization is not indicated for patients with asymptomatic intestinal arterial obstructions, except in patients undergoing aortic/renal artery surgery for other indications 1
- Fluoroquinolones should generally be avoided in patients with aortic aneurysms but may be considered if there is a compelling clinical indication and no other reasonable alternative 1
- The mean growth rate of AAA is approximately 0.26 cm/year, with larger aneurysms growing faster (up to 0.5 cm/year) 1